- Home
- BAX vs PEN Comparison
BAX vs PEN Comparison
Compare BAX & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAX
- PEN
- Stock Information
- Founded
- BAX 1931
- PEN 2004
- Country
- BAX United States
- PEN United States
- Employees
- BAX N/A
- PEN N/A
- Industry
- BAX Medical/Dental Instruments
- PEN Medical/Dental Instruments
- Sector
- BAX Health Care
- PEN Health Care
- Exchange
- BAX Nasdaq
- PEN Nasdaq
- Market Cap
- BAX 12.4B
- PEN 9.9B
- IPO Year
- BAX N/A
- PEN 2015
- Fundamental
- Price
- BAX $23.86
- PEN $256.09
- Analyst Decision
- BAX Hold
- PEN Strong Buy
- Analyst Count
- BAX 9
- PEN 16
- Target Price
- BAX $32.00
- PEN $302.93
- AVG Volume (30 Days)
- BAX 6.2M
- PEN 432.3K
- Earning Date
- BAX 11-07-2025
- PEN 10-29-2025
- Dividend Yield
- BAX 2.85%
- PEN N/A
- EPS Growth
- BAX N/A
- PEN 916.05
- EPS
- BAX N/A
- PEN 3.74
- Revenue
- BAX $10,887,000,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- BAX $7.38
- PEN $15.52
- Revenue Next Year
- BAX $3.78
- PEN $14.20
- P/E Ratio
- BAX N/A
- PEN $68.49
- Revenue Growth
- BAX 3.60
- PEN 12.92
- 52 Week Low
- BAX $21.33
- PEN $189.94
- 52 Week High
- BAX $38.29
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- BAX 53.25
- PEN 47.86
- Support Level
- BAX $21.59
- PEN $242.41
- Resistance Level
- BAX $23.16
- PEN $257.56
- Average True Range (ATR)
- BAX 0.62
- PEN 7.03
- MACD
- BAX 0.15
- PEN -1.00
- Stochastic Oscillator
- BAX 84.86
- PEN 62.21
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.